Today, on the basis of the decree of the Government of the Republic of Kazakhstan on behalf of the Head of State Kassym-Jomart Kemelevich Tokayev, we are sending domestic products to the neighboring fraternal Kyrgyz Republic – the QazVac vaccine, produced by the Research Institute of Biological Safety Problems, as humanitarian aid.
The QazVac vaccine was developed and produced within the framework of a scientific and technical program funded by the Ministry of Education and Science of the Republic of Kazakhstan.
The technology of developing the domestic QazVac vaccine was implemented through painstaking work and the use of advanced scientific experience of our scientists.
The QazVac vaccine has fully passed the examination and control of the Ministry of Health of the Republic of Kazakhstan.
At the moment, about 300 thousand doses of QazVac vaccine have been shipped from the Research Institute of Biological Safety Problems to the warehouses of SK-Pharmacy.
We expect that in September, a production series of QazVac vaccines will be released on the high-tech equipped lines of the plant under construction by the Akimat of Zhambyl region.
The production of the QazVac vaccine is under strict control of the Government of the Republic of Kazakhstan.
We will get rid of the coronavirus infection in the near future and return from the pandemic situation to the previous living conditions as soon as possible only through the use of a vaccine and full compliance with sanitary and hygienic requirements.